These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30821437)

  • 1. Highly Uniform Synthesis of Selenium Nanoparticles with EGFR Targeting and Tumor Microenvironment-Responsive Ability for Simultaneous Diagnosis and Therapy of Nasopharyngeal Carcinoma.
    Huang J; Huang W; Zhang Z; Lin X; Lin H; Peng L; Chen T
    ACS Appl Mater Interfaces; 2019 Mar; 11(12):11177-11193. PubMed ID: 30821437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
    Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
    Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
    Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
    Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
    Maya S; Sarmento B; Lakshmanan VK; Menon D; Jayakumar R
    J Biomed Nanotechnol; 2014 Aug; 10(8):1416-28. PubMed ID: 25016642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling.
    Hu WJ; Liu J; Zhong LK; Wang J
    Biomed Pharmacother; 2018 Jun; 102():681-688. PubMed ID: 29604587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment.
    Chen R; Huang Y; Wang L; Zhou J; Tan Y; Peng C; Yang P; Peng W; Li J; Gu Q; Sheng Y; Wang Y; Shao G; Zhang Q; Sun Y
    Biomater Sci; 2021 Mar; 9(6):2279-2294. PubMed ID: 33538278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR-targeted hybrid lipid nanoparticles for chemo-photothermal therapy against colorectal cancer cells.
    Fang F; Zhang X; Tang J; Wang Y; Xu J; Sun Y
    Chem Phys Lipids; 2023 Mar; 251():105280. PubMed ID: 36634728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.
    Tseng SH; Chou MY; Chu IM
    Int J Nanomedicine; 2015; 10():3663-85. PubMed ID: 26056447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A minimalist cancer cell membrane-shielded biomimetic nanoparticle for nasopharyngeal carcinoma active-targeting therapy.
    Sun S; Han R; Sun Y; Chen W; Zhao L; Guan X; Zhang W
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113909. PubMed ID: 38599076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-EGFR therapies in nasopharyngeal carcinoma.
    Chen X; Liang R; Zhu X
    Biomed Pharmacother; 2020 Nov; 131():110649. PubMed ID: 32836074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Black Phosphorus Quantum Dots Gated, Carbon-Coated Fe
    Zhang M; Wang W; Wu F; Graveran K; Zhang J; Wu C
    Chemistry; 2018 Sep; 24(49):12890-12901. PubMed ID: 29855103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High sensitivity of gold nanoparticles co-doped with Gd
    Wang H; Zhang S; Tian X; Liu C; Zhang L; Hu W; Shao Y; Li L
    Sci Rep; 2016 Oct; 6():34367. PubMed ID: 27694966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal cancer-specific therapy based on fusion peptide-functionalized lipid nanoparticles.
    Luo H; Lu L; Yang F; Wang L; Yang X; Luo Q; Zhang Z
    ACS Nano; 2014 May; 8(5):4334-47. PubMed ID: 24766601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.
    Boeckx C; Van den Bossche J; De Pauw I; Peeters M; Lardon F; Baay M; Wouters A
    BMC Res Notes; 2015 Jun; 8():203. PubMed ID: 26032726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxylated Mesoporous Nanosilica Coated by Polyethylenimine Coupled with Gadolinium and Folic Acid: A Tumor-Targeted T(1) Magnetic Resonance Contrast Agent and Drug Delivery System.
    Zhang G; Gao J; Qian J; Zhang L; Zheng K; Zhong K; Cai D; Zhang X; Wu Z
    ACS Appl Mater Interfaces; 2015 Jul; 7(26):14192-200. PubMed ID: 26084052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Magnetic Resonance Imaging and Modulation of Hypoxia with Multifunctional Hyaluronic Acid-MnO
    Fu C; Duan X; Cao M; Jiang S; Ban X; Guo N; Zhang F; Mao J; Huyan T; Shen J; Zhang LM
    Adv Healthc Mater; 2019 May; 8(10):e1900047. PubMed ID: 30920772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR.
    Lin Q; Wang H; Lin X; Zhang W; Huang S; Zheng Y
    Cancer Biother Radiopharm; 2018 Mar; 33(2):60-64. PubMed ID: 29634414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma.
    Li X; Zhao Z; Yi S; Ma L; Li M; Liu M; Zhang Y; Liu G
    J Transl Med; 2018 Jul; 16(1):183. PubMed ID: 29973197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies.
    Camorani S; Caliendo A; Morrone E; Agnello L; Martini M; Cantile M; Cerrone M; Zannetti A; La Deda M; Fedele M; Ricciardi L; Cerchia L
    J Exp Clin Cancer Res; 2024 Mar; 43(1):92. PubMed ID: 38532439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.